Mid Carolina Cardiology is a clinical research site located in Charlotte, North Carolina, United States 28204-3288.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Mid Carolina Cardiology has participated in 10 clinical trials.
Therapeutic areas: Diastolic Heart Failure, Pulmonary Arterial Hypertension, Heart Failure.
Sponsors: Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Abbott Medical Devices.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Mid Carolina Cardiology has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Carolina Cardiology has 10 clinical trials on record. Their work covers Diastolic Heart Failure, Pulmonary Arterial Hypertension, Heart Failure.
Yes — Mid Carolina Cardiology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.